Jupiter Neurosciences, Inc.
JUNS
$0.34
-$0.01-3.29%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 324.34% | 318.31% | 122.08% | 9.49% | -48.40% |
| Gross Profit | -319.91% | -318.31% | -122.08% | -9.49% | 48.40% |
| SG&A Expenses | 164.39% | 227.95% | 74.91% | 22.72% | -10.93% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 189.98% | 250.43% | 85.31% | 19.65% | -20.20% |
| Operating Income | -189.27% | -250.43% | -85.31% | -19.65% | 20.20% |
| Income Before Tax | -254.36% | -466.30% | -133.70% | 9.16% | 49.00% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -254.36% | -466.30% | -133.70% | 9.16% | 49.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -254.36% | -466.30% | -133.70% | 9.16% | 49.00% |
| EBIT | -189.27% | -250.43% | -85.31% | -19.65% | 20.20% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -211.65% | -380.33% | -88.96% | 26.49% | 55.96% |
| Normalized Basic EPS | -126.77% | -169.71% | -44.06% | -1.21% | 23.43% |
| EPS Diluted | -209.36% | -338.00% | -76.61% | 28.82% | 56.74% |
| Normalized Diluted EPS | -131.69% | -177.65% | -46.90% | 0.61% | 25.05% |
| Average Basic Shares Outstanding | 18.61% | 18.29% | 20.67% | 16.63% | 10.57% |
| Average Diluted Shares Outstanding | 15.59% | 15.14% | 17.32% | 19.52% | 13.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |